Kritika Rehani

Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disorder characterized by unbridled activation of cytotoxic T lymphocytes, natural killer (NK) cells, and macrophages resulting in hypercytokinemia and immune-mediated injury of multiple organ systems. DelveInsight’s  ‘ Hemophagocytic Lymphohistiocytosis Market Insights, Epidemiology, and Market Forecast – 2030 ’  report deliver an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Hemophagocytic Lymphohistiocytosis (HLH) in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.  The Hemophagocytic Lymphohistiocytosis market report provides analysis regarding current treatment practices, an emerging drug-like Tadekinig Alfa, potential therapies, market share of the individual therapies, and historical, current and forecasted Hemophagocytic Lymphohistiocytosis market size from 2017 to 2030 segmented by seven major markets. The re

Dravet syndrome (DS) is a rare, catastrophic, lifelong form of epilepsy that begins in the first year of life with frequent and/or prolonged seizures. Dravet Syndrome has been defined as a severe form of epilepsy characterized by frequent, prolonged seizures often triggered by high body temperature (hyperthermia), developmental delay, speech impairment, ataxia, hypotonia, sleep disturbances, and other health problems. DelveInsight’s  ‘ Dravet Syndrome Market Insights, Epidemiology, and Market Forecast – 2030 ’  report deliver an in-depth understanding of the disease, historical and forecasted epidemiology as well as the market trends of Dravet Syndrome (DS) in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.     The Dravet Syndrome market report provides analysis regarding current treatment practices, emerging drug-like Cannabidiol, potential therapies, market share of the individual therapies, historical, current and forecasted Drave

Oropharyngeal Cancer (OPC) Market Insights, Epidemiology and Market Forecast 2030 The oropharynx consists of the structures in the oral cavity , back of the throat , including the base of the tongue, palatine tonsils, posterior pharyngeal wall, and soft palate. These are the well-known areas can only be visualized using special endoscopes or mirrors. There are many types of cancer of the oropharynx. Oropharyngeal cancer is a type of head and neck cancer . Patients with oropharyngeal cancer related to HPV tend to present earlier in life as compared to those with tobacco-associated oropharyngeal cancer. The primary tumor is often difficult to see, hidden within the folds of the throat (tongue-base and tonsil.) DelveInsight's " Oropharyngeal Cancer - Market Insights, Epidemiology, and Market Forecast-2030 "  report delivers an in-depth understanding of the Oropharyngeal Cancer, historical and forecasted epidemiology as well as the Oropharyngeal Cancer market trends in

  Chimeric Antigen Receptor T Cell (CAR- T) Therapy for Non-Hodgkin’s Lymphoma (NHL) Market Chimeric antigen receptor (CAR) T-cell therapy involves genetic modification of patient’s autologous T-cells to express a CAR, specific for a tumor antigen, followed by ex vivo cell expansion and re-infusion back to the patient. CAR T-cells are the fusion proteins of a selected single-chain fragment variable from a specific monoclonal antibody and one or more T-cell receptor intracellular signaling domains. A CAR combines antigen-binding domains-most commonly, a single-chain variable fragment (scFv) derived from the variable domains of antibodies with the signalling domains of the TCR chain and additional costimulatory domains from receptors, such as CD28, OX40, and CD137 (Morgenstern & Irwin, 2019). T-cell genetic modification may occur either via viral-based gene transfer methods or non-viral methods, such as DNA-based transposons, CRISPR/Cas9 technology, zinc finger nuclease (ZFN), transc